Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Innovation Partnership Supports ENT Surgeries

By HospiMedica International staff writers
Posted on 20 Jul 2015
A new collaboration between Smith & Nephew (London, United Kingdom) and Scopis medical (Berlin, Germany) will advance complex advanced ear, nose, and throat (ENT) surgeries.

The partnership involves the integration and compatibility of Smith & Nephew’s ENT product range with the Scopis Target Guided Surgery (TGS) system, and the appointment of Smith & Nephew as exclusive distributor of the Scopis TGS in the United Kingdom, Ireland, and Belgium. More...
The TGS is a “next-generation” solution for navigated functional endoscopic sinus surgery (FESS) that offers surgeons highly advanced image guidance and visualization capabilities in a single system. During surgery, planned pathways are overlaid in real-time onto the endoscopic image, providing the surgeon with an augmented reality.

The analysis and planning in three dimensional (3-D) anatomy in TGS is based on the Building Blocks software, a unique solution that allows analysis and identification of sinus cells in complex patient anatomy, and planning of natural drainage pathways to the sinuses. A special guidance and alarm system assists surgeons to guide endoscopic instruments on the pathways direct to the targets. The hybrid navigation system offers electromagnetic, optical, and hybrid tracking technology in one unit, providing a solution that can be extended to interdisciplinary use in craniomaxillofacial (CMF) surgery and neurosurgery.

“The partnership demonstrates Smith & Nephew’s strategy desire to collaborate with companies sharing the same vision in providing healthcare professionals with innovative ENT technologies,” said Mike Gutteridge, unit director for Smith & Nephew’s European ENT business. “Partnering with manufacturers of complementary devices enables us to present the most complete product portfolio to ENT surgeons, delivering best in class technologies for surgery, patients and payers.”

“The partnership with Smith & Nephew as the exclusive distributor in the UK, Ireland, and Belgium in the ENT market allows us to propose our next-generation solutions for ENT surgery with the most professional expertise and support,” said Bartosz Kosmecki, CEO of Scopis. “Combining the Scopis TGS with Smith & Nephew’s ENT product portfolio extends our current minimal-invasive solutions for an even less invasive chronic sinusitis treatment with benefit for surgeons and patients.”

Related Links:

Smith & Nephew
Scopis Medical



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.